Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


CHU25 Maxi-Plus Cooled: High speed, high throughput electrophoresis with the maxi-plus cooled horizontal

Product Description
Scie-Plas™ Green Range™ horizontal gel electrophoresis units offer the ultimate standards in innovative design and manufacture, acquired during our 20-year existence. The Scie-Plas Green Range horizontal gel electrophoresis units currently comprise models with gel tray sizes ranging from 6 x 7.5 to 25 x 30cm. All models incorporate many design and safety features recommended by scientists, either from within our in-house product development team or laboratories worldwide. As a result, all our models are manufactured and finished to the highest specification, easy to use, and, with safety always paramount, CE-marked - conforming to European safety regulations.

The CHU25 Maxi-Plus cooled horizontal gel unit is designed specifically for rapid high throughput screening of nucleic acids, particularly PCR products and in genotyping studies. In addition to having the same 25 x 30cm gel-casting tray, 624-sample throughput, buffer recirculation ports and gel-casting features of its HU25 counterpart, the CHU25 has a labyrinthine cooling base situated directly within the tank. Once the gel is made, the gel-casting tray is simply lowered onto the cooling base, which may be connected either to the laboratory water supply or the optional JULABO chiller, optimised for enhanced cooling, allowing the user to perform high voltage electrophoretic separations faster and further without compromising resolution.

FEATURES

Complete System
Maxi-plus cooled horizontal gel unit with removable casting tray, including casting gates with integral silicone seals, 6 x 1mm thick, 26-sample combs, coloured loading strips and buffer recirculation ports
Unit Dimensions (W x L x H): 33 x 56 x 9cm
Gel Size (W x L): 25 x 30cm
Buffer Volume: 3000ml
Maximum Sample Capacity: 624
Recommended Power Supplies: Consort EV243
Product CHU25 Maxi-Plus Cooled: High speed, high throughput electrophoresis with the maxi-plus cooled horizontal
Company Scie-Plas Ltd
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity 1
Company Logo

Scie-Plas Ltd
22 Cambridge Science Park Milton Road Cambridge CB4 0FJ UK

Tel: +44 (0) 1223 427888
Fax: +44 (0) 1223 420164
Email: Sales@scie-plas.co.uk



Scientific News
Gene Therapy for Metabolic Liver Diseases
Researchers have tested gene therapy in pigs from hereditary tyrosinemia type 1, with corrected liver cells being transplanted into the diseased liver.
Gene Terapy for Muscle Wasting Developed
New gene therapy could save millions of people suffering from muscle wasting disease.
Gene-Editing 'Toolbox' Targets Multiple Genes Simultaneously
Researchers have designed a system that modifies, or edits, multiple genes in a genome at once while minimising unintentional effects.
Discovering the First Farmers
Genetic analyses reveal a collection of highly distinct groups in the Near East and Europe at the dawn of agriculture.
Fighting Cancer Through Protein Pathways
Researchers have found a new drug target within a protein production pathway critical to regulating growth and proliferation of cells.
Mutations in DNA-Repair Genes Found in Advanced Prostate Cancers
New findings indicate that nearly 12% of male advanced prostate cancer sufferers have inherited mutation in DNA-repair genes.
Ice Bucket Challenge Instrumental in Gene Discovery
Donations from the ALS Ice Bucket Chellenge allowed for the largest-ever study of inherited ALS, which identified a new ALS gene.
Triple-Action Therapy Patch Shows Promise
Patch that delivers drug, gene, and light-based therapy to tumor sites shows promising results in mice.
Cancer Gene-Drug Combinations Ripe for Precision Medicine
The study aims to expand the number of cancer gene mutations that can be paired with a precision therapy.
Targeting BRAF Mutations in Thyroid Cancer
Treating metastatic thyroid cancer patients harboring a BRAF mutation with vemurafenib showed anti-tumor activity in a third of patients.

Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!